KeyCorp Trims Schrödinger (NASDAQ:SDGR) Target Price to $25.00

Schrödinger (NASDAQ:SDGRGet Free Report) had its price objective lowered by stock analysts at KeyCorp from $30.00 to $25.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s target price would suggest a potential upside of 21.48% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Citigroup decreased their target price on Schrödinger from $39.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Craig Hallum cut their price target on Schrödinger from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Leerink Partnrs upgraded Schrödinger to a “strong-buy” rating in a research note on Tuesday, July 2nd. Finally, SVB Leerink assumed coverage on Schrödinger in a research note on Tuesday, July 2nd. They issued an “outperform” rating and a $29.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $38.90.

Check Out Our Latest Report on Schrödinger

Schrödinger Price Performance

Shares of NASDAQ SDGR opened at $20.58 on Thursday. Schrödinger has a 1-year low of $18.21 and a 1-year high of $59.24. The business has a 50-day moving average of $21.41 and a 200-day moving average of $25.65. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of -10.95 and a beta of 1.51.

Schrödinger (NASDAQ:SDGRGet Free Report) last issued its earnings results on Wednesday, May 1st. The company reported ($0.76) earnings per share for the quarter, hitting the consensus estimate of ($0.76). Schrödinger had a negative return on equity of 29.25% and a negative net margin of 75.94%. The company had revenue of $36.60 million during the quarter, compared to the consensus estimate of $41.23 million. Research analysts expect that Schrödinger will post -2.83 EPS for the current fiscal year.

Hedge Funds Weigh In On Schrödinger

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC grew its holdings in Schrödinger by 8.4% in the 4th quarter. SG Americas Securities LLC now owns 5,125 shares of the company’s stock worth $183,000 after buying an additional 397 shares in the last quarter. Texas Permanent School Fund Corp boosted its stake in Schrödinger by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 47,869 shares of the company’s stock valued at $1,292,000 after purchasing an additional 626 shares in the last quarter. GAMMA Investing LLC boosted its stake in Schrödinger by 49.5% during the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company’s stock valued at $41,000 after purchasing an additional 703 shares in the last quarter. ProShare Advisors LLC boosted its stake in Schrödinger by 7.4% during the 1st quarter. ProShare Advisors LLC now owns 10,987 shares of the company’s stock valued at $297,000 after purchasing an additional 753 shares in the last quarter. Finally, Illinois Municipal Retirement Fund boosted its stake in Schrödinger by 2.7% during the 1st quarter. Illinois Municipal Retirement Fund now owns 32,043 shares of the company’s stock valued at $865,000 after purchasing an additional 831 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

About Schrödinger

(Get Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Recommended Stories

Analyst Recommendations for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.